Future researches should be used to explore the potential regulation of MEK1 and evaluate the possible applications of MEK1 inhibitors in pan-cancer, which might provide promising therapeutic strategies and choices for cancer patients with MEK1 dysregulation. Here, MAP2K1 is linked to cancer.